Drug Shortage Report for SATIVEX
Report ID | 154632 |
Drug Identification Number | 02266121 |
Brand name | SATIVEX |
Common or Proper name | Sativex |
Company Name | GW PHARMA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CANNABIDIOL DELTA-9-TETRAHYDROCANNABINOL |
Strength(s) | 2.5MG 2.7MG |
Dosage form(s) | SPRAY |
Route of administration | BUCCAL BUCCAL |
Packaging size | 3 |
ATC code | N02BG |
ATC description | OTHER ANALGESICS AND ANTIPYRETICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-03-09 |
Estimated end date | 2022-03-18 |
Actual end date | 2022-03-18 |
Shortage status | Resolved |
Updated date | 2022-03-19 |
Company comments | For all inquiries please contact Bayer Medical Information on 1-800-265-7382 or email: canada.medinfo@bayer.com |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | VISION PARK HISTON, CAMBRIDGE, CAMBRIDGESHIRE UNITED KINGDOM CB2 9BZ |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2022-03-03 | English | Compare |
v15 | 2022-02-28 | French | Compare |
v14 | 2022-02-28 | English | Compare |
v13 | 2022-02-28 | French | Compare |
v12 | 2022-02-28 | English | Compare |
v11 | 2022-02-22 | French | Compare |
v10 | 2022-02-22 | English | Compare |
v9 | 2022-02-11 | French | Compare |
v8 | 2022-02-11 | English | Compare |
v7 | 2022-02-11 | French | Compare |
v6 | 2022-02-11 | English | Compare |
v5 | 2022-02-10 | English | Compare |
v4 | 2022-02-09 | French | Compare |
v3 | 2022-02-09 | French | Compare |
v2 | 2022-02-09 | English | Compare |
v1 | 2022-02-09 | English | Compare |